Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP853675.RA8-uup7RVoZcI1g0BrdSErak_ReiOVm5d1vaEjOcGTvI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP853675.RA8-uup7RVoZcI1g0BrdSErak_ReiOVm5d1vaEjOcGTvI130_assertion type Assertion NP853675.RA8-uup7RVoZcI1g0BrdSErak_ReiOVm5d1vaEjOcGTvI130_head.
- NP853675.RA8-uup7RVoZcI1g0BrdSErak_ReiOVm5d1vaEjOcGTvI130_assertion description "[High iASPP expression was significantly associated with clear cell carcinoma subtype (P = 0.003), carboplatin and paclitaxel chemoresistance (P = 0.04), shorter overall (P = 0.003), and disease-free (P = 0.001) survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP853675.RA8-uup7RVoZcI1g0BrdSErak_ReiOVm5d1vaEjOcGTvI130_provenance.
- NP853675.RA8-uup7RVoZcI1g0BrdSErak_ReiOVm5d1vaEjOcGTvI130_assertion evidence source_evidence_literature NP853675.RA8-uup7RVoZcI1g0BrdSErak_ReiOVm5d1vaEjOcGTvI130_provenance.
- NP853675.RA8-uup7RVoZcI1g0BrdSErak_ReiOVm5d1vaEjOcGTvI130_assertion SIO_000772 21926165 NP853675.RA8-uup7RVoZcI1g0BrdSErak_ReiOVm5d1vaEjOcGTvI130_provenance.
- NP853675.RA8-uup7RVoZcI1g0BrdSErak_ReiOVm5d1vaEjOcGTvI130_assertion wasDerivedFrom befree-20150227 NP853675.RA8-uup7RVoZcI1g0BrdSErak_ReiOVm5d1vaEjOcGTvI130_provenance.
- NP853675.RA8-uup7RVoZcI1g0BrdSErak_ReiOVm5d1vaEjOcGTvI130_assertion wasGeneratedBy ECO_0000203 NP853675.RA8-uup7RVoZcI1g0BrdSErak_ReiOVm5d1vaEjOcGTvI130_provenance.